CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas

(2018) Xiudong Guan et al.   EBioMedicine

SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma

(2018) Yongdong Jin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma

(2018) Xiaonian Zhu et al.   DNA AND CELL BIOLOGY

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

(2017) Riccardo Mezzadra et al.   NATURE

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

(2017) Marian L. Burr et al.   NATURE

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer

(2017) Jisela Dimas-González et al.   ONCOLOGY REPORTS

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

(2017) Jiahui Si et al.   World Journal of Surgical Oncology

Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients

(2016) Mingzi Zhang et al.   MEDICINE

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma

(2015) Ting Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CMTM8 inhibits the carcinogenesis and progression of bladder cancer

(2015) DENGHUI GAO et al.   ONCOLOGY REPORTS

CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma

(2014) Heyu Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

(2014) Y. Xiao et al.   Clinical & Translational Oncology

CMTM1_v17 is a novel potential therapeutic target in breast cancer

(2014) JING WANG et al.   ONCOLOGY REPORTS

CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis

(2014) Zesong Li et al.   PLoS One

Epidemiology of Breast Cancer

(2014) Kristen A. Ban et al.   Surgical Oncology Clinics of North America

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth

(2013) H Li et al.   ONCOGENE

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

(2013) Balázs Győrffy et al.   PLoS One

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

(2012) Christina Curtis et al.   NATURE

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

(2011) Pascal Jézéquel et al.   BREAST CANCER RESEARCH AND TREATMENT

Expressional and functional studies of CKLF1 during dendritic cell maturation

(2010) Luning Shao et al.   CELLULAR IMMUNOLOGY

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia

(2010) Jihong Niu et al.   LEUKEMIA RESEARCH

Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation

(2010) Markus Plate et al.   MOLECULES AND CELLS

CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-α

(2009) Xiaohuan Guo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CMTM5-v1 induces apoptosis in cervical carcinoma cells

(2009) Luning Shao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE